SCHEMBL6209532

SCHEMBL6209532

CC(C)(CC(N)=O)CC(=O)N1CCC2C1C(=O)CN2C(=O)c1ccccn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSK P43235 4/20 0.39
L3MBTL1 Q9Y468 1/20 0.37
RBP4 P02753 2/20 0.37
PLA2G1B P04054 1/20 0.35
ATG4B Q9Y4P1 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
NPC1 O15118 1/20 0.35
TP53 P04637 1/20 0.35
RAB9A P51151 1/20 0.35
NAMPT P43490 1/20 0.34
CTSL P07711 2/20 0.34
CTSS P25774 2/20 0.34
ADRA1D P25100 1/20 0.34
ADRA1A P35348 1/20 0.34
ADRA1B P35368 1/20 0.34
MAPK1 P28482 1/20 0.33
EPHX2 P34913 1/20 0.33
GAA P10253 1/20 0.33
ALDH1A1 P00352 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6210331 0.84 L3MBTL1 (0.40) CTSKL3MBTL1SMN1; SMN2NPC1RAB9A
SCHEMBL6209960 0.83 CTSK (0.39) CTSKL3MBTL1RBP4NAMPTCTSL
SCHEMBL6210371 0.81 CTSK (0.38) CTSKCTSLCTSS
SCHEMBL4043002 0.80 CTSK (0.45) CTSKL3MBTL1RBP4PLA2G1BATG4B
SCHEMBL4043000 0.80 CTSK (0.38) CTSKL3MBTL1RBP4PLA2G1BATG4B
SCHEMBL6209170 0.79 PARP1 (0.35) L3MBTL1SMN1; SMN2GAAALDH1A1TSHR
SCHEMBL4044468 0.78 L3MBTL1 (0.38) CTSKL3MBTL1SMN1; SMN2NPC1RAB9A
SCHEMBL6210592 0.78 PAX8 (0.40) CTSKALDH1A1CYP2C9
SCHEMBL4040770 0.77 CTSK (0.48) CTSKL3MBTL1CTSLCTSSADRA1D
SCHEMBL4044474 0.76 CTSK (0.42) CTSKL3MBTL1PLA2G1BATG4BCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546150-A1 BIOLOGICALLY ACTIVE COMPOUNDS Amura Therapeutics Limited (GB) 2005-06-29 EP claimed
WO-2004007501-A1 BIOLOGICALLY ACTIVE COMPOUNDS AMURA THERAPEUTICS LIMITED (GB) 2004-01-22 WO claimed
EP-1546150-A1 BIOLOGICALLY ACTIVE COMPOUNDS Amura Therapeutics Limited (GB) 2005-06-29 EP disclosed
WO-2004007501-A1 BIOLOGICALLY ACTIVE COMPOUNDS AMURA THERAPEUTICS LIMITED (GB) 2004-01-22 WO disclosed